15至39岁确诊癌症的20万五年生存者心脏死亡率研究
霍奇金淋巴瘤等癌种心脏死亡风险显著增加。
要点
- 癌症确诊年龄是后续心脏死亡风险的关键决定因素,越年轻风险越高。
- 15至19岁确诊者心脏疾病标准化死亡比为4.2,35至39岁为1.2。
- 霍奇金淋巴瘤生存者心脏死亡风险为一般人群的3.8倍。
核心结论
- 癌症确诊年龄是决定后续心脏死亡风险的关键因素,年轻确诊者风险更高。
- 研究首次基于大型人群队列得出15至39岁各癌种确诊后心脏死亡的风险估计。
研究设计与样本
- 计算标准化死亡比、绝对超额风险和累积风险。
主要发现
- 所有癌症合并的心脏疾病标准化死亡比在15至19岁确诊者中最高为4.2(95%CI 3.4-5.2),35至39岁降至1.2(95%CI 1.1-1.3),趋势P<0.0001。
- 缺血性心脏病、瓣膜性心脏病和心肌病的标准化死亡比和绝对超额风险呈现相似模式。
- 霍奇金淋巴瘤、急性髓系白血病、非膀胱泌尿生殖系统癌症、非霍奇金淋巴瘤、肺癌、非急性髓系白血病、中枢神经系统肿瘤、宫颈癌和乳腺癌生存者心脏死亡分别为一般人群期望值的3.8、2.7、2.0、1.7、1.7、1.6、1.4、1.3和1.2倍。
- 60岁以上霍奇金淋巴瘤生存者中,几乎30%的总超额死亡数由心脏病导致。
临床怎么用
- 对15至39岁确诊的癌症生存者,尤其是年轻确诊及霍奇金淋巴瘤等高风险癌种,应加强心脏健康监测。
- 研究证据为制定基于证据的随访指南提供了初步基础。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Survivors of teenage and young adult cancer are acknowledged as understudied. Little is known about their long-term adverse health risks, particularly of cardiac disease that is increased in other cancer populations where cardiotoxic treatments have been used. METHODS: The Teenage and Young Adult Cancer Survivor Study cohort comprises 200 945 5-year survivors of cancer diagnosed at 15 to 39 years of age in England and Wales from 1971 to 2006, and followed to 2014. Standardized mortality ratios, absolute excess risks, and cumulative risks were calculated. RESULTS: Two thousand sixteen survivors died of cardiac disease. For all cancers combined, the standardized mortality ratios for all cardiac diseases combined was greatest for individuals diagnosed at 15 to 19 years of age (4.2; 95% confidence interval, 3.4-5.2) decreasing to 1.2 (95% confidence interval, 1.1-1.3) for individuals aged 35 to 39 years (2P for trend <0.0001). Similar patterns were observed for both standardized mortality ratios and absolute excess risks for ischemic heart disease, valvular heart disease, and cardiomyopathy. Survivors of Hodgkin lymphoma, acute myeloid leukaemia, genitourinary cancers other than bladder cancer, non-Hodgkin lymphoma, lung cancer, leukaemia other than acute myeloid, central nervous system tumour, cervical cancer, and breast cancer experienced 3.8, 2.7, 2.0, 1.7, 1.7, 1.6, 1.4, 1.3 and 1.2 times the number of cardiac deaths expected from the general population, respectively. Among survivors of Hodgkin lymphoma aged over 60 years, almost 30% of the total excess number of deaths observed were due to heart disease. CONCLUSIONS: This study of over 200 000 cancer survivors shows that age at cancer diagnosis was critical in determining subsequent cardiac mortality risk. For the first time, risk estimates of cardiac death after each cancer diagnosed between the ages of 15 and 39 years have been derived from a large population-based cohort with prolonged follow-up. The evidence here provides an initial basis for developing evidence-based follow-up guidelines.
引用
- Henson KE, Reulen RC, Winter DL, et al. Cardiac Mortality Among 200 000 Five-Year Survivors of Cancer Diagnosed at 15 to 39 Years of Age: The Teenage and Young Adult Cancer Survivor Study. Circulation. 2016. PMID: 27821538
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。